Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024

PR NewswireOct 29 16:05 ET

Heron Therapeutics Reaffirms Treatment Supply After Hurricane Helene

WSJOct 10 17:06 ET

Heron Therapeutics: CINVANTI, in Combination With Other Antiemetic Agents, Is Indicated in Adults for Prevention of Nausea and Vomiting Associated With Cancer Chemotherapy >HRTX

Dow JonesOct 10 16:30 ET

Heron Therapeutics: Marion Facility Is Believed to Supply Up to 60% of the IV Fluid Market in U.S. >HRTX

Dow JonesOct 10 16:30 ET

Heron Therapeutics: Potential Disruption in Supply of Intravenously Administered Fluids Is Result of Temporary Closure of Suppliers' Manufacturing Site in Marion, N.C., Impacted by Hurricane Helene >HRTX

Dow JonesOct 10 16:30 ET

Express News | Heron Therapeutics Reaffirms Availability and Ample Supply of Cinvanti®, Sustol®, and Aponvie® as Alternatives During the Potential Shortage of Intravenous Fluids

ReutersOct 10 16:08 ET